Examkin

Soru

Zorluk: ZorBipolar and Related Disorders

A 35-year-old female marketing director is evaluated in the outpatient psychiatry clinic for a 4-week history of severely depressed mood. She reports sleeping up to 14 hours daily, profound fatigue, a 4-kg (8.8-lb) weight gain, and feelings of worthlessness. She states, 'My family would be better off if I were gone,' but she denies an active plan or intent for self-harm. Three years ago, she was brought to the emergency department after a 10-day period of sleeping only 2 hours per night, rapid speech, and impulsive spending that depleted her savings. She is currently medically healthy and takes no medications. Vital signs and physical examination are unremarkable. Following the evaluation, the patient's husband leaves a voicemail for the physician, requesting an update on his wife's condition. Which of the following are appropriate components of this patient's management plan? (Select all that apply)

  1. Initiate lurasidone monotherapyCevap
  2. Initiate quetiapine monotherapyCevap
  3. C
    Initiate sertraline monotherapy
  4. D
    Initiate a combination of fluoxetine and phenelzine
  5. E
    Return the husband's call and provide a detailed update on the treatment plan

Cevap

The appropriate management plan includes initiating either lurasidone monotherapy or quetiapine monotherapy.
This patient's history of a distinct 10-day period of decreased need for sleep, rapid speech, and severe impulsivity establishes a diagnosis of Bipolar I Disorder, and she is currently presenting in a major depressive episode. The treatment of acute bipolar depression differs significantly from unipolar major depressive disorder. First-line pharmacologic options that have proven efficacy and FDA approval for bipolar depression include atypical antipsychotics such as lurasidone, quetiapine, and cariprazine, as well as the olanzapine-fluoxetine combination. Therefore, initiating lurasidone or quetiapine monotherapy are both correct and appropriate interventions.

Adım Adım Çözüm

1
Analyze the patient's past psychiatric history.
The patient had a 10-day episode of decreased need for sleep, rapid speech, and impulsive spending.
This establishes a clear history of a manic episode, confirming a diagnosis of Bipolar I Disorder.
2
Assess the patient's current clinical presentation.
The patient is experiencing a major depressive episode characterized by hypersomnia, weight gain, fatigue, and passive suicidal ideation.
Recognizing the current phase is critical for selecting the appropriate pharmacotherapy (bipolar depression vs. acute mania).
3
Select appropriate pharmacologic agents for acute bipolar depression.
Lurasidone and quetiapine are identified as effective, FDA-approved first-line monotherapies.
Standard antidepressants (like sertraline) used as monotherapy risk triggering a manic episode and are generally avoided without concurrent mood stabilizers.
4
Evaluate the ethical dilemma regarding the husband's voicemail.
The physician must maintain patient confidentiality and cannot disclose information to the husband.
Although the patient expresses passive suicidal ideation, she lacks a specific plan or active intent, which means the threshold for breaching confidentiality to prevent imminent harm is not met.

Anahtar Kavram

First-line management of acute bipolar depression includes specific atypical antipsychotics (e.g., lurasidone, quetiapine), while avoiding antidepressant monotherapy due to the risk of mood destabilization.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Bipolar and Related Disorders

Bu konudan daha fazla soru